What are the treatment options for migraine management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Migraine Management

Acute Treatment Algorithm

For acute migraine treatment, start with NSAIDs for mild-to-moderate attacks, escalate to triptans for moderate-to-severe attacks or NSAID failures, and use combination therapy (triptan + NSAID) for optimal efficacy. 1

First-Line Treatment: NSAIDs

  • NSAIDs are the recommended first-line therapy for most migraine patients, with the strongest evidence supporting aspirin, ibuprofen, naproxen sodium, and diclofenac potassium. 2, 1

  • Acetaminophen alone is ineffective and should not be used as monotherapy. 2

  • The combination of acetaminophen-aspirin-caffeine is effective for mild attacks, but acetaminophen alone lacks efficacy. 2, 1

  • Ensure patients use adequate NSAID dosages before declaring treatment failure. 3

Second-Line Treatment: Triptans

  • Triptans should be used when NSAIDs provide inadequate relief or for moderate-to-severe attacks from the outset. 2, 1

  • All seven triptans have good evidence for efficacy: sumatriptan (oral and subcutaneous), rizatriptan, eletriptan, zolmitriptan, naratriptan, almotriptan, and frovatriptan. 2, 1

  • Administer triptans early in the attack while headache is still mild for maximum effectiveness. 1, 3

  • If one triptan fails, trial another—individual response varies significantly between triptans. 1

  • Combining a triptan with an NSAID improves efficacy beyond either agent alone. 1, 4

  • Subcutaneous sumatriptan is particularly useful for patients with severe nausea/vomiting who cannot tolerate oral medications. 1

Contraindications to Triptans

Triptans are contraindicated in patients with: 2, 5

  • Uncontrolled hypertension
  • Coronary artery disease or Prinzmetal's angina
  • History of stroke or transient ischemic attack
  • Basilar or hemiplegic migraine
  • Wolff-Parkinson-White syndrome or other cardiac accessory pathway disorders

Third-Line Treatment: Advanced Options

  • For patients who fail all triptans or have contraindications, consider CGRP antagonists (gepants: rimegepant, ubrogepant, zavegepant), lasmiditan (ditan), or dihydroergotamine. 1

Managing Associated Symptoms

  • Add antiemetics like metoclopramide or prochlorperazine for nausea/vomiting, which also improve gastric motility and medication absorption. 1, 4

  • Use non-oral routes (nasal spray, subcutaneous injection) when nausea/vomiting is prominent. 1

Critical Medications to Avoid

  • Do not use opioids or butalbital-containing analgesics for migraine treatment—they increase risk of medication overuse headache and dependency. 1, 3, 4

Medication Overuse Headache Prevention

  • Limit acute medication use to ≤10 days per month for triptans and ≤15 days per month for NSAIDs to prevent medication overuse headache. 1, 4

  • Consider preventive therapy if acute medications are needed more than twice weekly. 2

Preventive Treatment Indications

Consider preventive medications when patients have: 1

  • Two or more attacks per month producing disability lasting ≥3 days per month
  • Contraindication to or failure of acute treatments
  • Use of acute medication more than twice per week
  • Uncommon migraine conditions (hemiplegic migraine, prolonged aura)

Preventive Medication Options

  • First-line preventive options include beta-blockers (propranolol, timolol), topiramate, or candesartan. 1, 4

  • Topiramate requires discussion of teratogenic effects with patients of childbearing potential. 1

  • Alternative options include ACE inhibitors, ARBs, or SSRIs if first-line agents are not tolerated. 1

  • Start preventive medications at low doses and titrate gradually to desired effect. 1

Stratified vs. Step-Care Approach

  • The stratified-care approach (matching treatment intensity to attack severity from the outset) is superior to step-care (starting with simple analgesics and escalating only after failure). 2

  • Use NSAIDs for patients with mild disability and infrequent attacks. 2

  • Use triptans immediately for patients with moderate-to-severe disability. 2

Non-Pharmacologic Interventions

  • Counsel patients on lifestyle modifications: maintain regular meals, adequate hydration, consistent sleep schedule (7-9 hours), regular aerobic exercise, and stress management techniques. 1, 3, 4

  • Relaxation training, thermal biofeedback combined with relaxation, electromyographic biofeedback, and cognitive-behavioral therapy have evidence for migraine prevention. 2

  • Behavioral therapy can be combined with preventive medications for additive benefit. 2

Monitoring and Follow-Up

  • Have patients maintain a headache diary tracking severity, frequency, duration, disability, treatment response, and adverse effects. 2, 1

  • Encourage identification of migraine triggers (alcohol, caffeine, tyramine-containing foods, nitrates, stress, fatigue, perfumes, bright/flickering lights). 2

  • Switch preventive treatment if adequate response is not achieved during a reasonable trial period. 1

Special Populations

Pregnancy

  • Acetaminophen is the safest option during pregnancy. 6
  • Sumatriptan may be considered for selected patients and is compatible with breastfeeding. 6

Elderly

  • Blood pressure increases more significantly with triptans in elderly patients—monitor closely. 5
  • Pharmacokinetics are similar to younger adults, though half-life is slightly prolonged (4.4 to 5.7 hours). 5

Pediatric

  • Safety and effectiveness of triptans in pediatric patients are not established. 5

References

Guideline

Migraine Treatment Strategies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment Options for Ocular Migraines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment Options for Unilateral Headache

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute Migraine Treatment.

Continuum (Minneapolis, Minn.), 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.